University of Minnesota Designated as Rare Disease Center of Excellence
December 20, 2021
The National Organization for Rare Disorders (NORD) has announced that the University of Minnesota is among the initial cohort of institutions designated as Rare Disease Centers of Excellence.
The College of Pharmacy and the Center for Orphan Drug Research were prominently featured in the University’s application, which highlighted contributions in education at the undergraduate, professional, and graduate student levels; collegiate research; and community engagement activities such as Rare Disease Day.
The NORD designation also serves as the springboard for the University to work on the development of a rare disease center. The center will serve internally to bring together and better coordinate many patient care, education, and research activities. It will also outwardly serve as a landing page to facilitate patients, families, not-for-profit organizations, industry and government officials, and others connecting with us.
The development of a UMN Rare Disease Center of Excellence is being undertaken by a multidisciplinary planning committee, which is chaired by Dr. Susan Berry of the University of Minnesota Medical School and includes Dr. James Cloyd, a professor in the College of Pharmacy.
Media Contacts
Related Stories
Dr. Melanie Nicol, associate professor and director of graduate studies in the Department of Experimental and Clinical Pharmacology (ECP) received a new award of $3 million across the next five years from the National Institutes of Health (NIH).
Duerfeldt's research is focused on the development of chemical tools that can be utilized to enhance our understanding of disease mechanisms and the development of new therapeutic leads for bacterial infections and ocular diseases.
The Center for Drug Design (CDD), part of the University of Minnesota College of Pharmacy, created a novel technology using biomimetic decoy molecules to boost the skin's natural ability to mitigate ultraviolet-induced damage, a development that has the potential to revolutionize the skincare industry.